Clinical Trials Sponsored by Hospital Negrín

Total 101478 results

Mario Negri Institute for Pharmacological Research

Not yet recruiting

Reduction Of Dietary Salt Intake To Control Systolic Blood Pressure In Hypertensive Older Patients (REPRESS)

Hypertension
Mario Negri Institute for Pharmacological Research

Recruiting

B Cells in Idiopathic Nephrotic Syndrome (BLADE)

Nephrotic Syndrome

Italy
Mario Negri Institute for Pharmacological Research

Recruiting

Prophylactic Surgery Plus HIPEC With CO2 in Patients Affected by Gastric Carcinoma.GOETH Study (GOETH)

Stomach Neoplasms

Italy
Mario Negri Institute for Pharmacological Research

Active, not recruiting

Evaluation of the Quality of Care in the Emergency Department by Studying the Appropriateness of Admissions of Patients Accessing the Emergency Department (ASST Papa Giovanni XXIII)

Emergency Departments | Evaluation | Quality of Care | Appropriateness

Italy
Mario Negri Institute for Pharmacological Research

Completed

Thyroid Hormones in ADPKD (REORIENTED)

Autosomal Dominant Polycystic Kidney

Italy
Mario Negri Institute for Pharmacological Research

Withdrawn

COVID-19 Algorithm Treatment at Home (COVER-HOME)

COVID-19
Mario Negri Institute for Pharmacological Research

Terminated

Mesenchymal Stem Cells Under Basiliximab/Low Dose RATG to Induce Renal Transplant Tolerance (MSC-KTX)

Kidney Transplant

Italy
Mario Negri Institute for Pharmacological Research

Terminated

Genetic Study of Nephrolithiasis in Gouty Diathesis

Nephrolithiasis

Italy
Mario Negri Institute for Pharmacological Research

Completed

Effects of an Intensified Treatment With ACE-I,ATA II and Statins in Alport Syndrome

Alport Syndrome

Italy
Mario Negri Institute for Pharmacological Research

Completed

A Simple Approach to Prevent Hospitalization for COVID-19 Patients (COVER2)

Covid19

Italy
Mario Negri Institute for Pharmacological Research

Completed

COVID-19 Impact on the Lombardy Region's Emergency System

Covid19

Italy
Mario Negri Institute for Pharmacological Research

Active, not recruiting

Remission Clinic in Proteinuric Chronic Nephropathies

Chronic Kidney Disease

Italy
Mario Negri Institute for Pharmacological Research

Completed

A Simple Approach to Treat COVID-19 Patients at Home. (COVER)

COVID 19

Italy
Mario Negri Institute for Pharmacological Research

Completed

Decision-aid on Breast Cancer Screening

Breast Cancer

Italy
Mario Negri Institute for Pharmacological Research

Terminated

Insulin Treatment in Diabetic Older People With Heart Failure. (Insulin-HF)

Heart Failure | Diabetes Mellitus, Type 2

Italy
Mario Negri Institute for Pharmacological Research

Completed

An Efficacy Study Of Ortataxel In Recurrent Glioblastoma (Ortataxel)

Glioblastoma

Italy
Mario Negri Institute for Pharmacological Research

Completed

E-learning to Improve Oral Anticoagulant Use in Hospitalized Older People With AF (SIM-AF)

Atrial Fibrillation | Elderly | Geriatrics | Simulation Training | Anticoagulant Drugs | Internal Medicine | Drug Prescriptions

Italy
Mario Negri Institute for Pharmacological Research

Terminated

Outcome-related Factors in Patients With Metastatic Renal Cell Carcinoma Treated With Everolimus (ORCHIDEE) (ORCHIDEE)

Renal Cell Carcinoma

Italy
Mario Negri Institute for Pharmacological Research

Completed

Somatostatin In Patients With Autosomal Dominant Polycystic Kidney Disease And Moderate To Severe Renal Insufficiency (ALADIN2)

Autosomal Dominant Polycystic Kidney Disease

Italy
Mario Negri Institute for Pharmacological Research

Completed

Prospective Longitudinal Observational Study to Evaluate the Clinical Characteristics and Opioids Treatments in Patients With Breakthrough Cancer Pain (RER)

Neuropathic Pain | Tumor | Cancer Pain | Breakthrough Cancer Pain

Italy
Mario Negri Institute for Pharmacological Research

Completed

RCT Comparing the Analgesic Efficacy of 4 Therapeutic Strategies Based on 4 Different Major Opioids (Fentanyl, Oxycodone, Buprenorphine vs Morphine) in Cancer Patients With Moderate/Severe Pain, at the Moment of Starting 3rd Step of WHO Analgesic Ladder. (CERP)

Cancer | Cancer Pain

Italy
Mario Negri Institute for Pharmacological Research

Completed

Multicentric Observational Study on Quality of Life in Glaucoma

Primary Open-angle Glaucoma

Italy
Mario Negri Institute for Pharmacological Research

Terminated

Renal and Systemic Effects of NCX4016 in Patients With Type 2 Diabetes and Early Nephropathy

Type 2 Diabetes | Early Nephropathy

Italy
Mario Negri Institute for Pharmacological Research

Completed

Intensive Versus Minimal Surveillance of Patients With Resected Dukes B2-C Colorectal Carcinoma (GILDA)

Colorectal Cancer | Surveillance
Consorzio Mario Negri Sud
Artsana SpA

Completed

Efficacy, Safety and Satisfaction of the New Pen Needle 33 Gauge x 4 mm. (AGO01)

Type 1 Diabetes | Type 2 Diabetes

Italy
Mario Negri Institute for Pharmacological Research

Completed

Telmisartan Versus Losartan in Kidney Transplantation (COSTANT)

Renal Transplant

Italy
Mario Negri Institute for Pharmacological Research

Completed

Risk and Prevention Study: Evaluation of the Efficacy of n-3 PUFA in Subjects at High Cardiovascular Risk

Cardiovascular Diseases

Italy
Mario Negri Institute for Pharmacological Research

Completed

Acetylcarnitine and Insulin Sensitivity

Type 2 Diabetes Mellitus

Italy
Mario Negri Institute for Pharmacological Research

Completed

Metabolic and Renal Effects of Rosiglitazone in Kidney Transplant

Kidney Transplant

Italy
Newron Sweden AB
Medtronic; TFS Trial Form Support

Completed

A Follow-up Study on Safety and Tolerability of Intracerebroventricular Administration of sNN0031 to Patients With Parkinson's Disease

Parkinson's Disease

Sweden
Yolanda Lopez Fernandez
Hospital Infantil Universitario Niño Jesús, Madrid, Spain; Dr. Negrin University... and other collaborators

Recruiting

Prevalence AND Outcome of Acute Hypoxemic Respiratory fAilure in CHILDren (PANDORA-CHILD) (PANDORA-child)

Acute Respiratory Insufficiency

Spain
JOSE IVAN RODRIGUEZ DE MOLINA SERRANO

Completed

LPP , MP and DP:Relation With Mortality and SOFA in Mechanically Ventilated Patients in ER, Ward and ICU (LUMEDRI-MORT)

Mechanical Ventilation Complication | Mechanical Power | Driving Pressure | Lung Protective Ventilation

Mexico
Mario Negri Institute for Pharmacological Research
PharmaMar

Completed

ATREUS - Phase II Study on the Activity of Trabectedin in Patients With Malignant Pleural Mesothelioma (MPM) (ATREUS)

Malignant Pleural Mesothelioma

Italy
Mario Negri Institute for Pharmacological Research
PharmaMar

Completed

Activity of Trabectedin or Gemcitabine + Docetaxel in Uterine Leiomyosarcoma (TAUL)

Leiomyosarcoma

Italy
Parc de Salut Mar
Hospital Clinic of Barcelona; Universidad Complutense de Madrid; Hospital Universitario... and other collaborators

Not yet recruiting

REstoration of VItamin D in Pulmonary Arterial Hypertension (REVIDAH)

Pulmonary Artery Hypertension | Vitamin d Deficiency
Ente Ospedaliero Ospedali Galliera
Istituto Di Ricerche Farmacologiche Mario Negri; Humanitas Hospital, Italy

Recruiting

Letrozole for Estrogen/Progesterone Receptor Positive Low-grade Serous Epithelial Ovarian Cancer (LEPRE Trial) (LEPRE)

Carcinoma, Ovarian Epithelial | Low Grade Serous Adenocarcinoma of Ovary

Italy
Mario Negri Institute for Pharmacological Research
Bayer

Completed

Peripheral Artery Disease in Patients With Stable Coronary Artery Disease in General Practice: Prevalence, Management and Clinical Outcomes. (PAD&CAD)

Peripheral Artery Disease

Italy
Mario Negri Institute for Pharmacological Research
AstraZeneca

Unknown

Best Approach in Recurrent-Ovarian-Cancer-with Cediranib-Olaparib (BAROCCO)

Ovarian Neoplasms

Italy
Mario Negri Institute for Pharmacological Research
Abbott

Completed

Salt Intake and Antiproteinuric Effect of Paricalcitol in Type 2 Diabetes (PROCEED)

Type 2 Diabetes

Italy
Mario Negri Institute for Pharmacological Research
AstraZeneca

Recruiting

First Line Treatment With Olaparib in Combination With Bevacizumab in HRD Positive Patients (IOLANTHE)

Carcinoma, Ovarian Epithelial

Italy
Mario Negri Institute for Pharmacological Research
AstraZeneca

Completed

Dapagliflozin in Non-diabetic Stage IV CKD (ADAPT)

Chronic Kidney Diseases

Italy
Mario Negri Institute for Pharmacological Research
ChemoCentryx

Terminated

Complement Inhibition in aHUS Dialysis Patients (ACCESS)

Atypical Hemolytic Uremic Syndrome

Italy
Charles University, Czech Republic
Na Homolce Hospital; Nemocnice AGEL Trinec-Podlesi a.s.; Neuron Medical s.r.o.

Recruiting

Pulsed-field Ablation vs. Sham Ablation to Treat AF

Atrial Fibrillation

Czechia
Neuron, Spain
Centro Superior de Estudios Universitarios La Salle

Recruiting

Transcranial Magnetic Stimulation on Somtosensory Cortex Enhances Motor Learning in People With Stroke

Stroke | Transcranial Magnetic Stimulation | Motor Learning

Spain
Antea Foundation
Istituto Di Ricerche Farmacologiche Mario Negri

Recruiting

Evaluation of ESMO Guidelines Applicability and Adherence in Cancer Pain Management in the Palliative Care Setting

Pain | Cancer | Cancer Pain

Italy
Mario Negri Institute for Pharmacological Research
Boehringer Ingelheim

Withdrawn

SGLT2 Inhibitors in Glomerular Hyperfiltration (EMPATHY)

Obesity | Non-diabetic Chronic Kidney Disease
Mario Negri Institute for Pharmacological Research
Alnylam Pharmaceuticals

Withdrawn

Eculizumab to Cemdisiran Switch in aHUS (DANCE)

Atypical Hemolytic Uremic Syndrome

Italy
Mario Negri Institute for Pharmacological Research
MorphoSys AG

Active, not recruiting

MOR202 for Refractory MN (MONET)

Membranous Nephropathy

Italy
Mario Negri Institute for Pharmacological Research
Fondazione Telethon

Completed

Familiar Fatal Insomnia: Preventive Treatment With Doxycycline in Subject With Disease Risk (FFI)

Familial Fatal Insomnia
Mario Negri Institute for Pharmacological Research
Novartis Pharmaceuticals

Terminated

A Prevention Trial of Canakinumab in Subjects at High Risk for Lung Cancer (CANAL)

Lung Cancer

Italy

Clinical Trials Sponsored by Hospital Negrín

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Dominican Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations